Pages that link to "Item:Q915680"
From MaRDI portal
The following pages link to Role of optimal control theory in cancer chemotherapy (Q915680):
Displaying 50 items.
- Personalized drug administration for cancer treatment using model reference adaptive control (Q300902) (← links)
- Stochastic models in biology and the invariance problem (Q316925) (← links)
- Existence of solutions and optimal control for a model of tissue invasion by solid tumours (Q401410) (← links)
- Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments (Q415424) (← links)
- A survey of optimization models on cancer chemotherapy treatment planning (Q478056) (← links)
- Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint (Q478655) (← links)
- Fastest time to cancer by loss of tumor suppressor genes (Q486643) (← links)
- Dynamics and control of a mathematical model for metronomic chemotherapy (Q745131) (← links)
- A stochastic two-stage carcinogenesis model: A new approach to computing the probability of observing tumor in animal bioassays (Q758076) (← links)
- Optimal control of an HIV model with CTL cells and latently infected cells (Q779627) (← links)
- The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB (Q933282) (← links)
- Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy (Q997317) (← links)
- A model for cancer chemotherapy with state-space constraints (Q1000089) (← links)
- On optimal delivery of combination therapy for tumors (Q1042733) (← links)
- Singularity of optimal control in some problems related to optimal chemotherapy (Q1327291) (← links)
- Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle (Q1340483) (← links)
- Chemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effects (Q1361432) (← links)
- Conflicting objectives in chemotherapy with drug resistance (Q1364689) (← links)
- The influence of fixed and free final time of treatment on optimal chemotherapeutic protocols (Q1388959) (← links)
- The modelling of the immune competition by generalized kinetic (Boltzmann) models: Review and research perspectives (Q1410904) (← links)
- Bifurcation analysis for a mean field modelling of tumor and immune system competition (Q1433134) (← links)
- Modelling and mathematical problems related to tumor evolution and its interaction with the immune system (Q1585820) (← links)
- Application of optimal control theory to analysis of cancer chemotherapy regimens (Q1607229) (← links)
- Critical analysis and perspectives on kinetic (cellular) theory of immune competition (Q1609376) (← links)
- Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy (Q1653067) (← links)
- Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia (Q1712819) (← links)
- Bounding the dynamics of a chaotic-cancer mathematical model (Q1721728) (← links)
- The combined effects of optimal control in cancer remission (Q1732198) (← links)
- Bone metastasis treatment modeling via optimal control (Q1738035) (← links)
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472) (← links)
- Drug kinetics and drug resistance in optimal chemotherapy (Q1804871) (← links)
- Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity (Q1804872) (← links)
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy (Q1862197) (← links)
- Stochastic optimal therapy for enhanced immune response (Q1886329) (← links)
- Conceptual frameworks for mathematical modeling of tumor growth dynamics (Q1921075) (← links)
- Optimal medication for tumors modeled by a Cahn-Hilliard-Brinkman equation (Q2002008) (← links)
- On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
- On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
- Mathematical analysis and optimal control applied to the treatment of leukemia (Q2053080) (← links)
- Optimal control of viral infection model with saturated infection rate (Q2061356) (← links)
- Pitfalls in applying optimal control to dynamical systems: an overview and editorial perspective (Q2081952) (← links)
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach (Q2131714) (← links)
- Stochastic modeling of drug resistance in cancer (Q2195074) (← links)
- Optimization of interleukin-21 immunotherapeutic strategies (Q2211591) (← links)
- Cancer immunotherapy, mathematical modeling and optimal control (Q2219776) (← links)
- Numerical optimal control of a size-structured PDE model for metastatic cancer treatment (Q2328437) (← links)
- Optimal control and pattern formation for a haptotaxis model of solid tumor invasion (Q2334162) (← links)
- Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control (Q2335463) (← links)
